Susan Berland

Senior Financial Executive

Susan Berland has served as a member of our board of directors since June 2021. Most recently Ms. Berland was the Acting Chief Financial Officer (CFO) of Bluestar Genomics. Prior to Bluestar Genomics, she was CFO at Atreca, a biotechnology company developing novel immunotherapies where she played a key role in closing several strategic financings. As a consultant to the life sciences industry, she has advised numerous companies and was a co-founder of Veracyte Inc. Ms. Berland held leadership positions at Monsanto Company as Head of Financial Planning and as Director of Mergers & Acquisitions.

Ms. Berland earned MBA and BA degrees from the University of Wisconsin – Milwaukee.